Oncothyreon: Possible Pharma Blockbuster -Seeking Alpha

Oncothyreon's ONTY Stimuvax phase 3 trial very likely to be successful according to Seeking Alpha report.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!